{"gene":"DRD3","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2017,"finding":"Drd3 signaling in lateral septum (LS) neurons mediates early life stress (ELS)-induced social dysfunction: ELS downregulates Drd3 signaling in LS, blunting Drd3LS neuronal Ca2+ responses to social stimuli; optogenetic activation of Drd3LS neurons rescues social impairments, and pharmacological Drd3 agonist treatment normalizes social dysfunction.","method":"In vivo Ca2+ imaging, optogenetics, pharmacological agonist treatment, conditional loss-of-function in mice","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Ca2+ imaging, optogenetics, pharmacology) in a single rigorous study with gain- and loss-of-function","pmids":["29276054"],"is_preprint":false},{"year":2021,"finding":"DRD3-dependent plasticity in ventral pallidum (VP) drives potentiation of accumbal dopamine release during relapse to cocaine seeking after abstinence; two distinct VP DRD3+ neuronal populations project to lateral habenula (LHb) or VTA with different activity patterns during drug seeking, and selective suppression of elevated activity or DRD3 signaling in the LHb-projecting population reduces cocaine seeking.","method":"Circuit-specific optogenetics, DRD3 signaling manipulation, dopamine release imaging, cocaine self-administration model in mice","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal circuit-level and molecular methods with specific behavioral readouts","pmids":["34048697"],"is_preprint":false},{"year":2014,"finding":"The circadian protein NPAS2 directly transcriptionally regulates Drd3 expression in nucleus accumbens (NAc) Drd1-expressing neurons; NPAS2 knockdown in NAc disrupts the diurnal rhythm of Drd3 expression and decreases cocaine reward, while chronic cocaine disrupts normal Npas2 and Drd3 expression rhythms.","method":"AAV-shRNA knockdown, chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), cell sorting qRT-PCR, conditioned place preference assay in mice","journal":"Biological Psychiatry","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-seq direct binding evidence combined with KD phenotype and behavioral assays","pmids":["25444159"],"is_preprint":false},{"year":2016,"finding":"Drd3 palmitoylation acts as a molecular switch for biased signaling via GIPC1: palmitoylation remodels the C-terminal cytoplasmic domain to expose docking sites for GIPC1 (G-alpha interacting protein C-terminus 1), altering Drd3 trafficking and signaling; this was shown by molecular dynamics simulation, live imaging, and biochemical analyses of palmitoylation-deficient mutants.","method":"Molecular dynamics simulation, biochemical co-immunoprecipitation, live-cell imaging, site-directed mutagenesis of palmitoylation site","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — combined in silico modeling, mutagenesis, biochemical pulldown, and live imaging in a single study","pmids":["26787837"],"is_preprint":false},{"year":2019,"finding":"DRD3 (but not DRD2) activates autophagy through MTORC1 inhibition without suppressing protein synthesis: DRD3 activates AMPK, which inhibitorily phosphorylates RPTOR, leading to MTORC1 and RPS6KB1 inhibition and ULK1 activation; the MAPK1/3-RPS6KA pathway maintains RPS6 activity and protein synthesis is preserved despite MTORC1 inhibition.","method":"DRD3-overexpressing cells, drd3 KO mice, pramipexole treatment, Western blotting for AMPK/MTOR pathway components, LC3/GFP-LC3 autophagy assays, cell viability assays","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1–2 — KO vs. overexpression comparison with multiple pathway readouts and pharmacological validation","pmids":["31538542"],"is_preprint":false},{"year":2022,"finding":"PPX exerts neuroprotection via Drd3-dependent enhancement of autophagy in astrocytes: PPX dose-dependently increases autophagy (LC3-II, BECN1, GFP-LC3 puncta) and suppresses astrocytic NLRP3 inflammasome activation (cleaved caspase-1, IL-1β, ASC); these effects are abolished by Drd3 depletion and blocked by autophagy inhibitors, demonstrating the Drd3→autophagy→NLRP3 axis.","method":"Drd3 siRNA knockdown in primary astrocytes and in vivo, LPS-induced PD mouse model, NLRP3 inflammasome protein assays, autophagy markers, astrocyte-specific Atg5 knockdown","journal":"Acta Pharmacologica Sinica","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function (Drd3 depletion, Atg5 KD) combined with in vitro and in vivo validation using multiple mechanistic readouts","pmids":["35896696"],"is_preprint":false},{"year":2004,"finding":"DRD3 mediates expression of conditioned effects of morphine: DRD3-knockout mice show altered morphine conditioned place preference (CPP) sensitivity, and the DRD3-selective partial agonist BP897 inhibits morphine-CPP and reduces c-fos activation in the somatosensory cortex only in wild-type but not drd3-/- mice.","method":"DRD3-knockout mice, conditioned place preference assay, c-fos imaging, pharmacological DRD3 partial agonist","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 — KO + pharmacological intervention with defined behavioral and molecular readouts, single lab","pmids":["15371743"],"is_preprint":false},{"year":2010,"finding":"HERV-W env overexpression in human glioma cells upregulates DRD3 expression alongside BDNF, NTRK2, and CREB phosphorylation; CREB is required for BDNF expression regulated by env, suggesting env triggers a signaling cascade that includes DRD3 upregulation.","method":"HERV-W env overexpression in U251 cells, gene knockdown, BDNF promoter reporter assay, RT-PCR, phosphorylation assays","journal":"Schizophrenia Bulletin","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect upregulation of DRD3 as part of broader pathway without direct mechanistic interrogation of DRD3 itself","pmids":["20100784"],"is_preprint":false},{"year":2006,"finding":"Proposed that neurofibromin (NF1) forms a binding complex with amyloid precursor protein (APP) which through filamin proteins interacts with DRD3, potentially affecting vesicular trafficking; identified by gene expression profiling and network analysis in Nf1+/- mouse hippocampus.","method":"Gene expression microarray (Affymetrix), network analysis in Nf1+/- mouse hippocampus","journal":"BMC Neuroscience","confidence":"Low","confidence_rationale":"Tier 4 — computational/expression-based inference only, no direct biochemical validation of the DRD3-APP-NF1 complex","pmids":["16524466"],"is_preprint":false}],"current_model":"DRD3 is a G protein-coupled dopamine receptor that (1) signals through GIPC1 in a palmitoylation-dependent manner to regulate its own trafficking and biased signaling, (2) activates an AMPK→MTORC1 inhibition→ULK1 autophagy axis (distinct from DRD2) while preserving protein synthesis via MAPK1/3-RPS6KA, (3) is expressed in lateral septum neurons where its activity is necessary and sufficient for normal social behavior downstream of early life stress, (4) drives cocaine-seeking relapse via a VP→lateral habenula circuit, and (5) is a direct transcriptional target of the circadian protein NPAS2 in nucleus accumbens, linking circadian timing to dopamine receptor expression and drug reward."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing that DRD3 is required for conditioned drug reward answered whether this receptor subtype has a non-redundant role in associative reward learning beyond DRD2.","evidence":"DRD3-knockout mice and DRD3-selective partial agonist BP897 tested in morphine conditioned place preference with c-fos mapping","pmids":["15371743"],"confidence":"Medium","gaps":["Downstream signaling pathways mediating conditioned reward were not identified","Results from a single lab without independent replication","No comparison with DRD2-specific manipulations in the same paradigm"]},{"year":2014,"claim":"Demonstrating that the circadian protein NPAS2 directly binds and transcriptionally regulates Drd3 in nucleus accumbens established that DRD3 expression is under circadian transcriptional control, linking clock mechanisms to dopamine receptor availability and cocaine reward.","evidence":"ChIP-seq for NPAS2 binding at Drd3 locus, AAV-shRNA knockdown of NPAS2 in NAc, cell-sorting qRT-PCR, conditioned place preference in mice","pmids":["25444159"],"confidence":"High","gaps":["Whether other clock genes redundantly regulate Drd3 is unknown","Post-transcriptional regulation of DRD3 protein rhythms not assessed","Causal role of Drd3 rhythm itself in cocaine reward not isolated from other NPAS2 targets"]},{"year":2016,"claim":"Showing that palmitoylation remodels the DRD3 C-terminal domain to expose a GIPC1 docking site resolved how a single post-translational modification can switch DRD3 between signaling and trafficking modes.","evidence":"Molecular dynamics simulation, co-immunoprecipitation, live-cell imaging, and palmitoylation-site mutagenesis","pmids":["26787837"],"confidence":"High","gaps":["Identity of the palmitoyl acyltransferase(s) modifying DRD3 is unknown","Functional consequences of GIPC1-dependent trafficking in neurons in vivo not tested","Whether palmitoylation-dependent bias extends to G-protein versus β-arrestin signaling not resolved"]},{"year":2017,"claim":"Demonstrating that DRD3 signaling in lateral septum neurons is both necessary and sufficient for normal social behavior—and that early life stress blunts this pathway—established a specific circuit-level function for DRD3 beyond reward.","evidence":"In vivo Ca2+ imaging, optogenetic activation and inhibition of Drd3-expressing LS neurons, pharmacological DRD3 agonist rescue in early-life-stress mouse model","pmids":["29276054"],"confidence":"High","gaps":["Intracellular signaling cascade downstream of DRD3 in LS neurons not delineated","Epigenetic mechanism by which ELS downregulates Drd3 not identified","Whether DRD3 LS function generalizes across species unknown"]},{"year":2019,"claim":"Identifying that DRD3 activates autophagy through AMPK→RPTOR→MTORC1 inhibition→ULK1 while maintaining protein synthesis via MAPK1/3-RPS6KA distinguished a DRD3-specific signaling branch from DRD2 and linked dopamine receptor activation to autophagy regulation.","evidence":"DRD3-overexpressing cells, Drd3-knockout mice, pramipexole treatment, Western blotting for AMPK/MTOR/ULK1/MAPK pathway components, LC3 autophagy assays","pmids":["31538542"],"confidence":"High","gaps":["Physiological stimuli that engage this pathway in vivo not defined","Whether the AMPK-MTORC1 axis operates in neurons versus glia not resolved","Structural basis for DRD3-selective AMPK activation unknown"]},{"year":2021,"claim":"Mapping DRD3-dependent plasticity in ventral pallidum neurons projecting to lateral habenula as a driver of cocaine-seeking relapse identified the circuit through which DRD3 controls drug relapse after abstinence.","evidence":"Circuit-specific optogenetics, DRD3 signaling manipulation, dopamine release imaging in VP→LHb and VP→VTA projections during cocaine self-administration and relapse","pmids":["34048697"],"confidence":"High","gaps":["Molecular nature of the DRD3-dependent plasticity in VP neurons not characterized","Whether VP DRD3 function generalizes to other drugs of abuse not tested","Contribution of DRD3 heteromerization in VP not addressed"]},{"year":2022,"claim":"Extending the DRD3-autophagy link to astrocytes and demonstrating that DRD3-driven autophagy suppresses NLRP3 inflammasome activation provided a neuroimmune mechanism for DRD3 agonist neuroprotection.","evidence":"Drd3 siRNA and Atg5 knockdown in primary astrocytes and LPS-induced PD mouse model, NLRP3 inflammasome and autophagy marker assays","pmids":["35896696"],"confidence":"High","gaps":["Whether endogenous dopamine engages this axis at physiological concentrations unknown","Selectivity of the effect for astrocytes versus microglia or neurons not fully dissected","Long-term in vivo neuroprotective efficacy not established"]},{"year":null,"claim":"The structural basis for DRD3-selective activation of AMPK, the identity of palmitoyl transferases that modify DRD3, and how DRD3 heteromerization influences circuit-level functions remain open questions.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of DRD3 in complex with GIPC1 or downstream effectors","Epigenetic mechanisms by which early life stress downregulates Drd3 in lateral septum not identified","Role of DRD3 heteromers (e.g., DRD1-DRD3) in any of the described circuits not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,4,5,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,4,5,6]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[2]}],"complexes":[],"partners":["GIPC1","NPAS2"],"other_free_text":[]},"mechanistic_narrative":"DRD3 is a G protein-coupled dopamine receptor that couples dopaminergic signaling to intracellular trafficking, autophagy, and circuit-level control of social and reward-related behavior. Palmitoylation of DRD3 remodels its cytoplasmic domain to recruit the adaptor GIPC1, functioning as a molecular switch for biased signaling and receptor trafficking [PMID:26787837]. DRD3 activates an AMPK→MTORC1 inhibition→ULK1 autophagy axis distinct from DRD2, while preserving protein synthesis via MAPK1/3-RPS6KA signaling; in astrocytes this DRD3-dependent autophagy suppresses NLRP3 inflammasome activation [PMID:31538542, PMID:35896696]. In the brain, DRD3 is a direct transcriptional target of the circadian factor NPAS2 in nucleus accumbens, mediates early-life-stress-induced social dysfunction in lateral septum neurons, and drives cocaine-seeking relapse through a ventral pallidum→lateral habenula circuit [PMID:25444159, PMID:29276054, PMID:34048697]."},"prefetch_data":{"uniprot":{"accession":"P35462","full_name":"D(3) dopamine receptor","aliases":["Dopamine D3 receptor"],"length_aa":400,"mass_kda":44.2,"function":"Dopamine receptor that is primarily expressed in limbic areas of the brain and is involved in the modulation of cognitive, emotional, and endocrine functions (PubMed:39984436). Plays a key role in regulating neuronal signaling pathways associated with motivation, reward, and behavior (PubMed:39984436). Coupled to G(i)/G(o) proteins; activation leads to inhibition of adenylate cyclase and decreased intracellular cAMP levels (PubMed:10578130). Involved in the control of locomotor activity and implicated in several neuropsychiatric disorders, including schizophrenia and substance use disorders (PubMed:39984436). Promotes cell proliferation through MAP kinase signaling (PubMed:19520868). Also involved in autophagy regulation: receptor activation stimulates AMPK, which phosphorylates RPTOR and enhances its interaction with MTOR, thereby inhibiting MTORC1 signaling and its downstream target RPS6KB1. This leads to activation of ULK1 and initiation of the autophagy cascade (PubMed:31538542). Forms heterotetramers with DRD1 to potentiate beta-arrestin recruitment and mediate locomotor activity (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35462/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DRD3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DRD3","total_profiled":1310},"omim":[{"mim_id":"615433","title":"CHROMOSOME 3q13.31 DELETION SYNDROME","url":"https://www.omim.org/entry/615433"},{"mim_id":"614655","title":"STUTTERING, FAMILIAL PERSISTENT, 3; STUT3","url":"https://www.omim.org/entry/614655"},{"mim_id":"601768","title":"SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1","url":"https://www.omim.org/entry/601768"},{"mim_id":"190300","title":"TREMOR, HEREDITARY ESSENTIAL, 1; ETM1","url":"https://www.omim.org/entry/190300"},{"mim_id":"181500","title":"SCHIZOPHRENIA; SCZD","url":"https://www.omim.org/entry/181500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":5.2}],"url":"https://www.proteinatlas.org/search/DRD3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P35462","domains":[{"cath_id":"1.20.1070.10","chopping":"28-223_323-400","consensus_level":"high","plddt":90.3075,"start":28,"end":400}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35462","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35462-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35462-F1-predicted_aligned_error_v6.png","plddt_mean":75.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DRD3","jax_strain_url":"https://www.jax.org/strain/search?query=DRD3"},"sequence":{"accession":"P35462","fasta_url":"https://rest.uniprot.org/uniprotkb/P35462.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35462/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35462"}},"corpus_meta":[{"pmid":"19562769","id":"PMC_19562769","title":"Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19562769","citation_count":130,"is_preprint":false},{"pmid":"29276054","id":"PMC_29276054","title":"Drd3 Signaling in the Lateral Septum Mediates Early Life Stress-Induced Social Dysfunction.","date":"2017","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29276054","citation_count":101,"is_preprint":false},{"pmid":"14681904","id":"PMC_14681904","title":"Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14681904","citation_count":99,"is_preprint":false},{"pmid":"16513329","id":"PMC_16513329","title":"Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/16513329","citation_count":96,"is_preprint":false},{"pmid":"20100784","id":"PMC_20100784","title":"Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia.","date":"2010","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/20100784","citation_count":91,"is_preprint":false},{"pmid":"9674978","id":"PMC_9674978","title":"Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9674978","citation_count":90,"is_preprint":false},{"pmid":"19464960","id":"PMC_19464960","title":"DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.","date":"2009","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/19464960","citation_count":80,"is_preprint":false},{"pmid":"9491816","id":"PMC_9491816","title":"The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9491816","citation_count":74,"is_preprint":false},{"pmid":"25444159","id":"PMC_25444159","title":"Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.","date":"2014","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25444159","citation_count":72,"is_preprint":false},{"pmid":"9514583","id":"PMC_9514583","title":"European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514583","citation_count":72,"is_preprint":false},{"pmid":"10686561","id":"PMC_10686561","title":"COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10686561","citation_count":69,"is_preprint":false},{"pmid":"19058789","id":"PMC_19058789","title":"A common variant in DRD3 receptor is associated with autism spectrum disorder.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19058789","citation_count":63,"is_preprint":false},{"pmid":"9154247","id":"PMC_9154247","title":"DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder.","date":"1996","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9154247","citation_count":63,"is_preprint":false},{"pmid":"9790747","id":"PMC_9790747","title":"Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9790747","citation_count":63,"is_preprint":false},{"pmid":"34048697","id":"PMC_34048697","title":"Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking.","date":"2021","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/34048697","citation_count":62,"is_preprint":false},{"pmid":"8950413","id":"PMC_8950413","title":"Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8950413","citation_count":58,"is_preprint":false},{"pmid":"10893495","id":"PMC_10893495","title":"Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10893495","citation_count":57,"is_preprint":false},{"pmid":"23365649","id":"PMC_23365649","title":"The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23365649","citation_count":53,"is_preprint":false},{"pmid":"19396436","id":"PMC_19396436","title":"Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.","date":"2009","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19396436","citation_count":50,"is_preprint":false},{"pmid":"17407504","id":"PMC_17407504","title":"Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.","date":"2007","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/17407504","citation_count":49,"is_preprint":false},{"pmid":"10697826","id":"PMC_10697826","title":"Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.","date":"1999","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10697826","citation_count":49,"is_preprint":false},{"pmid":"21691864","id":"PMC_21691864","title":"Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD).","date":"2012","source":"Journal of autism and developmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/21691864","citation_count":48,"is_preprint":false},{"pmid":"11673801","id":"PMC_11673801","title":"Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11673801","citation_count":47,"is_preprint":false},{"pmid":"7860086","id":"PMC_7860086","title":"An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk.","date":"1994","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/7860086","citation_count":47,"is_preprint":false},{"pmid":"12860355","id":"PMC_12860355","title":"Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.","date":"2003","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/12860355","citation_count":46,"is_preprint":false},{"pmid":"9017973","id":"PMC_9017973","title":"Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia.","date":"1997","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/9017973","citation_count":46,"is_preprint":false},{"pmid":"21663922","id":"PMC_21663922","title":"Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.","date":"2011","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21663922","citation_count":45,"is_preprint":false},{"pmid":"18348205","id":"PMC_18348205","title":"A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18348205","citation_count":44,"is_preprint":false},{"pmid":"19439249","id":"PMC_19439249","title":"Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19439249","citation_count":44,"is_preprint":false},{"pmid":"16395310","id":"PMC_16395310","title":"A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16395310","citation_count":44,"is_preprint":false},{"pmid":"10523822","id":"PMC_10523822","title":"Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence.","date":"1999","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10523822","citation_count":43,"is_preprint":false},{"pmid":"11104840","id":"PMC_11104840","title":"DRD3 and DAT1 genes in schizophrenia: an association study.","date":"2000","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/11104840","citation_count":43,"is_preprint":false},{"pmid":"35896696","id":"PMC_35896696","title":"Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/35896696","citation_count":40,"is_preprint":false},{"pmid":"19897343","id":"PMC_19897343","title":"The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: case-control studies and an updated meta-analysis.","date":"2010","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19897343","citation_count":38,"is_preprint":false},{"pmid":"10670776","id":"PMC_10670776","title":"A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.","date":"2000","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10670776","citation_count":38,"is_preprint":false},{"pmid":"15371743","id":"PMC_15371743","title":"Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice.","date":"2004","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/15371743","citation_count":37,"is_preprint":false},{"pmid":"10889555","id":"PMC_10889555","title":"Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10889555","citation_count":37,"is_preprint":false},{"pmid":"17924589","id":"PMC_17924589","title":"Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting.","date":"2008","source":"Human psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17924589","citation_count":36,"is_preprint":false},{"pmid":"19506579","id":"PMC_19506579","title":"A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.","date":"2009","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/19506579","citation_count":36,"is_preprint":false},{"pmid":"19766158","id":"PMC_19766158","title":"Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19766158","citation_count":36,"is_preprint":false},{"pmid":"25224105","id":"PMC_25224105","title":"Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge.","date":"2014","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25224105","citation_count":35,"is_preprint":false},{"pmid":"19217756","id":"PMC_19217756","title":"Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.","date":"2009","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19217756","citation_count":35,"is_preprint":false},{"pmid":"22940547","id":"PMC_22940547","title":"Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.","date":"2012","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/22940547","citation_count":34,"is_preprint":false},{"pmid":"17429404","id":"PMC_17429404","title":"Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17429404","citation_count":30,"is_preprint":false},{"pmid":"24398431","id":"PMC_24398431","title":"DRD3 variation associates with early-onset heroin dependence, but not specific personality traits.","date":"2014","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24398431","citation_count":29,"is_preprint":false},{"pmid":"31538542","id":"PMC_31538542","title":"DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31538542","citation_count":28,"is_preprint":false},{"pmid":"24021960","id":"PMC_24021960","title":"Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder.","date":"2013","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24021960","citation_count":28,"is_preprint":false},{"pmid":"9149327","id":"PMC_9149327","title":"No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample.","date":"1996","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9149327","citation_count":28,"is_preprint":false},{"pmid":"12893467","id":"PMC_12893467","title":"No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence.","date":"1996","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/12893467","citation_count":27,"is_preprint":false},{"pmid":"18316228","id":"PMC_18316228","title":"Reappraisal of the role of the DRD3 gene in essential tremor.","date":"2008","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18316228","citation_count":27,"is_preprint":false},{"pmid":"9577839","id":"PMC_9577839","title":"Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9577839","citation_count":27,"is_preprint":false},{"pmid":"17125970","id":"PMC_17125970","title":"Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17125970","citation_count":27,"is_preprint":false},{"pmid":"20698735","id":"PMC_20698735","title":"The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.","date":"2010","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20698735","citation_count":27,"is_preprint":false},{"pmid":"19358223","id":"PMC_19358223","title":"The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: a meta-analysis.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19358223","citation_count":26,"is_preprint":false},{"pmid":"19309018","id":"PMC_19309018","title":"Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19309018","citation_count":26,"is_preprint":false},{"pmid":"25792691","id":"PMC_25792691","title":"DRD3 gene and striatum in autism spectrum disorder.","date":"2015","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/25792691","citation_count":26,"is_preprint":false},{"pmid":"24649110","id":"PMC_24649110","title":"Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.","date":"2014","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/24649110","citation_count":25,"is_preprint":false},{"pmid":"15342129","id":"PMC_15342129","title":"Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15342129","citation_count":25,"is_preprint":false},{"pmid":"18472202","id":"PMC_18472202","title":"The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.","date":"2008","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18472202","citation_count":24,"is_preprint":false},{"pmid":"25927430","id":"PMC_25927430","title":"Association of DRD3, COMT, and SLC6A4 Gene Polymorphisms with Type 2 Diabetes in Southern Chinese: A Hospital-Based Case-Control Study.","date":"2015","source":"Diabetes technology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25927430","citation_count":23,"is_preprint":false},{"pmid":"19353703","id":"PMC_19353703","title":"Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19353703","citation_count":23,"is_preprint":false},{"pmid":"26857559","id":"PMC_26857559","title":"A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26857559","citation_count":23,"is_preprint":false},{"pmid":"18449897","id":"PMC_18449897","title":"Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18449897","citation_count":22,"is_preprint":false},{"pmid":"18484990","id":"PMC_18484990","title":"DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients.","date":"2008","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18484990","citation_count":22,"is_preprint":false},{"pmid":"19645064","id":"PMC_19645064","title":"Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19645064","citation_count":21,"is_preprint":false},{"pmid":"17698325","id":"PMC_17698325","title":"No association between the DRD3 Ser9Gly polymorphism and schizophrenia.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17698325","citation_count":20,"is_preprint":false},{"pmid":"11378841","id":"PMC_11378841","title":"Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11378841","citation_count":20,"is_preprint":false},{"pmid":"27779245","id":"PMC_27779245","title":"Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.","date":"2016","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/27779245","citation_count":20,"is_preprint":false},{"pmid":"15083167","id":"PMC_15083167","title":"Association between schizophrenia and DRD3 or HTR2 receptor gene variants.","date":"2004","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15083167","citation_count":20,"is_preprint":false},{"pmid":"31143436","id":"PMC_31143436","title":"The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson's Disease.","date":"2019","source":"Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/31143436","citation_count":19,"is_preprint":false},{"pmid":"25262640","id":"PMC_25262640","title":"Significant association between DRD3 gene body methylation and schizophrenia.","date":"2014","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/25262640","citation_count":19,"is_preprint":false},{"pmid":"29361389","id":"PMC_29361389","title":"Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.","date":"2018","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/29361389","citation_count":19,"is_preprint":false},{"pmid":"16524466","id":"PMC_16524466","title":"Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.","date":"2006","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16524466","citation_count":19,"is_preprint":false},{"pmid":"16759339","id":"PMC_16759339","title":"No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.","date":"2006","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/16759339","citation_count":19,"is_preprint":false},{"pmid":"30464483","id":"PMC_30464483","title":"Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/30464483","citation_count":18,"is_preprint":false},{"pmid":"26627941","id":"PMC_26627941","title":"Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26627941","citation_count":17,"is_preprint":false},{"pmid":"24776816","id":"PMC_24776816","title":"DRD3 gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans.","date":"2014","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24776816","citation_count":16,"is_preprint":false},{"pmid":"20667458","id":"PMC_20667458","title":"Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.","date":"2010","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20667458","citation_count":16,"is_preprint":false},{"pmid":"18987889","id":"PMC_18987889","title":"A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia.","date":"2008","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18987889","citation_count":16,"is_preprint":false},{"pmid":"19302829","id":"PMC_19302829","title":"Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19302829","citation_count":16,"is_preprint":false},{"pmid":"27817855","id":"PMC_27817855","title":"Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.","date":"2016","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27817855","citation_count":14,"is_preprint":false},{"pmid":"26376054","id":"PMC_26376054","title":"Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.","date":"2015","source":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)","url":"https://pubmed.ncbi.nlm.nih.gov/26376054","citation_count":14,"is_preprint":false},{"pmid":"19524641","id":"PMC_19524641","title":"DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19524641","citation_count":14,"is_preprint":false},{"pmid":"29249220","id":"PMC_29249220","title":"DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.","date":"2017","source":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","url":"https://pubmed.ncbi.nlm.nih.gov/29249220","citation_count":13,"is_preprint":false},{"pmid":"30051166","id":"PMC_30051166","title":"DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.","date":"2018","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30051166","citation_count":13,"is_preprint":false},{"pmid":"29791666","id":"PMC_29791666","title":"Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia.","date":"2018","source":"Revista latino-americana de enfermagem","url":"https://pubmed.ncbi.nlm.nih.gov/29791666","citation_count":13,"is_preprint":false},{"pmid":"31798476","id":"PMC_31798476","title":"Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia.","date":"2019","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31798476","citation_count":12,"is_preprint":false},{"pmid":"20236178","id":"PMC_20236178","title":"Dopamine receptor 3 (DRD3) polymorphism and risk for migraine.","date":"2010","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20236178","citation_count":12,"is_preprint":false},{"pmid":"25264289","id":"PMC_25264289","title":"Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.","date":"2014","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25264289","citation_count":12,"is_preprint":false},{"pmid":"22877924","id":"PMC_22877924","title":"Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.","date":"2012","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22877924","citation_count":11,"is_preprint":false},{"pmid":"17018139","id":"PMC_17018139","title":"No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population.","date":"2006","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/17018139","citation_count":11,"is_preprint":false},{"pmid":"15051179","id":"PMC_15051179","title":"Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population.","date":"2004","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/15051179","citation_count":11,"is_preprint":false},{"pmid":"29357295","id":"PMC_29357295","title":"Association study of BDNF and DRD3 genes with alcohol use disorder in Schizophrenia.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29357295","citation_count":10,"is_preprint":false},{"pmid":"27665700","id":"PMC_27665700","title":"Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients.","date":"2016","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/27665700","citation_count":10,"is_preprint":false},{"pmid":"30005280","id":"PMC_30005280","title":"Differential effect of the DRD3 genotype on inflammatory cytokine responses during abstinence in amphetamine-dependent women.","date":"2018","source":"Psychoneuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30005280","citation_count":9,"is_preprint":false},{"pmid":"20672519","id":"PMC_20672519","title":"[Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].","date":"2010","source":"Psychiatria polska","url":"https://pubmed.ncbi.nlm.nih.gov/20672519","citation_count":9,"is_preprint":false},{"pmid":"26787837","id":"PMC_26787837","title":"A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26787837","citation_count":8,"is_preprint":false},{"pmid":"27909828","id":"PMC_27909828","title":"The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection.","date":"2016","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/27909828","citation_count":8,"is_preprint":false},{"pmid":"27456607","id":"PMC_27456607","title":"A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor.","date":"2016","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/27456607","citation_count":7,"is_preprint":false},{"pmid":"27447243","id":"PMC_27447243","title":"Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence.","date":"2016","source":"Drug metabolism and personalized therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27447243","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49570,"output_tokens":2424,"usd":0.092535},"stage2":{"model":"claude-opus-4-6","input_tokens":5736,"output_tokens":2254,"usd":0.127545},"total_usd":0.22008,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"Drd3 signaling in lateral septum (LS) neurons mediates early life stress (ELS)-induced social dysfunction: ELS downregulates Drd3 signaling in LS, blunting Drd3LS neuronal Ca2+ responses to social stimuli; optogenetic activation of Drd3LS neurons rescues social impairments, and pharmacological Drd3 agonist treatment normalizes social dysfunction.\",\n      \"method\": \"In vivo Ca2+ imaging, optogenetics, pharmacological agonist treatment, conditional loss-of-function in mice\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Ca2+ imaging, optogenetics, pharmacology) in a single rigorous study with gain- and loss-of-function\",\n      \"pmids\": [\"29276054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DRD3-dependent plasticity in ventral pallidum (VP) drives potentiation of accumbal dopamine release during relapse to cocaine seeking after abstinence; two distinct VP DRD3+ neuronal populations project to lateral habenula (LHb) or VTA with different activity patterns during drug seeking, and selective suppression of elevated activity or DRD3 signaling in the LHb-projecting population reduces cocaine seeking.\",\n      \"method\": \"Circuit-specific optogenetics, DRD3 signaling manipulation, dopamine release imaging, cocaine self-administration model in mice\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal circuit-level and molecular methods with specific behavioral readouts\",\n      \"pmids\": [\"34048697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The circadian protein NPAS2 directly transcriptionally regulates Drd3 expression in nucleus accumbens (NAc) Drd1-expressing neurons; NPAS2 knockdown in NAc disrupts the diurnal rhythm of Drd3 expression and decreases cocaine reward, while chronic cocaine disrupts normal Npas2 and Drd3 expression rhythms.\",\n      \"method\": \"AAV-shRNA knockdown, chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), cell sorting qRT-PCR, conditioned place preference assay in mice\",\n      \"journal\": \"Biological Psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq direct binding evidence combined with KD phenotype and behavioral assays\",\n      \"pmids\": [\"25444159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drd3 palmitoylation acts as a molecular switch for biased signaling via GIPC1: palmitoylation remodels the C-terminal cytoplasmic domain to expose docking sites for GIPC1 (G-alpha interacting protein C-terminus 1), altering Drd3 trafficking and signaling; this was shown by molecular dynamics simulation, live imaging, and biochemical analyses of palmitoylation-deficient mutants.\",\n      \"method\": \"Molecular dynamics simulation, biochemical co-immunoprecipitation, live-cell imaging, site-directed mutagenesis of palmitoylation site\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — combined in silico modeling, mutagenesis, biochemical pulldown, and live imaging in a single study\",\n      \"pmids\": [\"26787837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DRD3 (but not DRD2) activates autophagy through MTORC1 inhibition without suppressing protein synthesis: DRD3 activates AMPK, which inhibitorily phosphorylates RPTOR, leading to MTORC1 and RPS6KB1 inhibition and ULK1 activation; the MAPK1/3-RPS6KA pathway maintains RPS6 activity and protein synthesis is preserved despite MTORC1 inhibition.\",\n      \"method\": \"DRD3-overexpressing cells, drd3 KO mice, pramipexole treatment, Western blotting for AMPK/MTOR pathway components, LC3/GFP-LC3 autophagy assays, cell viability assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — KO vs. overexpression comparison with multiple pathway readouts and pharmacological validation\",\n      \"pmids\": [\"31538542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPX exerts neuroprotection via Drd3-dependent enhancement of autophagy in astrocytes: PPX dose-dependently increases autophagy (LC3-II, BECN1, GFP-LC3 puncta) and suppresses astrocytic NLRP3 inflammasome activation (cleaved caspase-1, IL-1β, ASC); these effects are abolished by Drd3 depletion and blocked by autophagy inhibitors, demonstrating the Drd3→autophagy→NLRP3 axis.\",\n      \"method\": \"Drd3 siRNA knockdown in primary astrocytes and in vivo, LPS-induced PD mouse model, NLRP3 inflammasome protein assays, autophagy markers, astrocyte-specific Atg5 knockdown\",\n      \"journal\": \"Acta Pharmacologica Sinica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function (Drd3 depletion, Atg5 KD) combined with in vitro and in vivo validation using multiple mechanistic readouts\",\n      \"pmids\": [\"35896696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DRD3 mediates expression of conditioned effects of morphine: DRD3-knockout mice show altered morphine conditioned place preference (CPP) sensitivity, and the DRD3-selective partial agonist BP897 inhibits morphine-CPP and reduces c-fos activation in the somatosensory cortex only in wild-type but not drd3-/- mice.\",\n      \"method\": \"DRD3-knockout mice, conditioned place preference assay, c-fos imaging, pharmacological DRD3 partial agonist\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO + pharmacological intervention with defined behavioral and molecular readouts, single lab\",\n      \"pmids\": [\"15371743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HERV-W env overexpression in human glioma cells upregulates DRD3 expression alongside BDNF, NTRK2, and CREB phosphorylation; CREB is required for BDNF expression regulated by env, suggesting env triggers a signaling cascade that includes DRD3 upregulation.\",\n      \"method\": \"HERV-W env overexpression in U251 cells, gene knockdown, BDNF promoter reporter assay, RT-PCR, phosphorylation assays\",\n      \"journal\": \"Schizophrenia Bulletin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect upregulation of DRD3 as part of broader pathway without direct mechanistic interrogation of DRD3 itself\",\n      \"pmids\": [\"20100784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Proposed that neurofibromin (NF1) forms a binding complex with amyloid precursor protein (APP) which through filamin proteins interacts with DRD3, potentially affecting vesicular trafficking; identified by gene expression profiling and network analysis in Nf1+/- mouse hippocampus.\",\n      \"method\": \"Gene expression microarray (Affymetrix), network analysis in Nf1+/- mouse hippocampus\",\n      \"journal\": \"BMC Neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/expression-based inference only, no direct biochemical validation of the DRD3-APP-NF1 complex\",\n      \"pmids\": [\"16524466\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DRD3 is a G protein-coupled dopamine receptor that (1) signals through GIPC1 in a palmitoylation-dependent manner to regulate its own trafficking and biased signaling, (2) activates an AMPK→MTORC1 inhibition→ULK1 autophagy axis (distinct from DRD2) while preserving protein synthesis via MAPK1/3-RPS6KA, (3) is expressed in lateral septum neurons where its activity is necessary and sufficient for normal social behavior downstream of early life stress, (4) drives cocaine-seeking relapse via a VP→lateral habenula circuit, and (5) is a direct transcriptional target of the circadian protein NPAS2 in nucleus accumbens, linking circadian timing to dopamine receptor expression and drug reward.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DRD3 is a G protein-coupled dopamine receptor that couples dopaminergic signaling to intracellular trafficking, autophagy, and circuit-level control of social and reward-related behavior. Palmitoylation of DRD3 remodels its cytoplasmic domain to recruit the adaptor GIPC1, functioning as a molecular switch for biased signaling and receptor trafficking [PMID:26787837]. DRD3 activates an AMPK→MTORC1 inhibition→ULK1 autophagy axis distinct from DRD2, while preserving protein synthesis via MAPK1/3-RPS6KA signaling; in astrocytes this DRD3-dependent autophagy suppresses NLRP3 inflammasome activation [PMID:31538542, PMID:35896696]. In the brain, DRD3 is a direct transcriptional target of the circadian factor NPAS2 in nucleus accumbens, mediates early-life-stress-induced social dysfunction in lateral septum neurons, and drives cocaine-seeking relapse through a ventral pallidum→lateral habenula circuit [PMID:25444159, PMID:29276054, PMID:34048697].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that DRD3 is required for conditioned drug reward answered whether this receptor subtype has a non-redundant role in associative reward learning beyond DRD2.\",\n      \"evidence\": \"DRD3-knockout mice and DRD3-selective partial agonist BP897 tested in morphine conditioned place preference with c-fos mapping\",\n      \"pmids\": [\"15371743\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling pathways mediating conditioned reward were not identified\", \"Results from a single lab without independent replication\", \"No comparison with DRD2-specific manipulations in the same paradigm\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that the circadian protein NPAS2 directly binds and transcriptionally regulates Drd3 in nucleus accumbens established that DRD3 expression is under circadian transcriptional control, linking clock mechanisms to dopamine receptor availability and cocaine reward.\",\n      \"evidence\": \"ChIP-seq for NPAS2 binding at Drd3 locus, AAV-shRNA knockdown of NPAS2 in NAc, cell-sorting qRT-PCR, conditioned place preference in mice\",\n      \"pmids\": [\"25444159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other clock genes redundantly regulate Drd3 is unknown\", \"Post-transcriptional regulation of DRD3 protein rhythms not assessed\", \"Causal role of Drd3 rhythm itself in cocaine reward not isolated from other NPAS2 targets\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing that palmitoylation remodels the DRD3 C-terminal domain to expose a GIPC1 docking site resolved how a single post-translational modification can switch DRD3 between signaling and trafficking modes.\",\n      \"evidence\": \"Molecular dynamics simulation, co-immunoprecipitation, live-cell imaging, and palmitoylation-site mutagenesis\",\n      \"pmids\": [\"26787837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the palmitoyl acyltransferase(s) modifying DRD3 is unknown\", \"Functional consequences of GIPC1-dependent trafficking in neurons in vivo not tested\", \"Whether palmitoylation-dependent bias extends to G-protein versus β-arrestin signaling not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that DRD3 signaling in lateral septum neurons is both necessary and sufficient for normal social behavior—and that early life stress blunts this pathway—established a specific circuit-level function for DRD3 beyond reward.\",\n      \"evidence\": \"In vivo Ca2+ imaging, optogenetic activation and inhibition of Drd3-expressing LS neurons, pharmacological DRD3 agonist rescue in early-life-stress mouse model\",\n      \"pmids\": [\"29276054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling cascade downstream of DRD3 in LS neurons not delineated\", \"Epigenetic mechanism by which ELS downregulates Drd3 not identified\", \"Whether DRD3 LS function generalizes across species unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identifying that DRD3 activates autophagy through AMPK→RPTOR→MTORC1 inhibition→ULK1 while maintaining protein synthesis via MAPK1/3-RPS6KA distinguished a DRD3-specific signaling branch from DRD2 and linked dopamine receptor activation to autophagy regulation.\",\n      \"evidence\": \"DRD3-overexpressing cells, Drd3-knockout mice, pramipexole treatment, Western blotting for AMPK/MTOR/ULK1/MAPK pathway components, LC3 autophagy assays\",\n      \"pmids\": [\"31538542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological stimuli that engage this pathway in vivo not defined\", \"Whether the AMPK-MTORC1 axis operates in neurons versus glia not resolved\", \"Structural basis for DRD3-selective AMPK activation unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapping DRD3-dependent plasticity in ventral pallidum neurons projecting to lateral habenula as a driver of cocaine-seeking relapse identified the circuit through which DRD3 controls drug relapse after abstinence.\",\n      \"evidence\": \"Circuit-specific optogenetics, DRD3 signaling manipulation, dopamine release imaging in VP→LHb and VP→VTA projections during cocaine self-administration and relapse\",\n      \"pmids\": [\"34048697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular nature of the DRD3-dependent plasticity in VP neurons not characterized\", \"Whether VP DRD3 function generalizes to other drugs of abuse not tested\", \"Contribution of DRD3 heteromerization in VP not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extending the DRD3-autophagy link to astrocytes and demonstrating that DRD3-driven autophagy suppresses NLRP3 inflammasome activation provided a neuroimmune mechanism for DRD3 agonist neuroprotection.\",\n      \"evidence\": \"Drd3 siRNA and Atg5 knockdown in primary astrocytes and LPS-induced PD mouse model, NLRP3 inflammasome and autophagy marker assays\",\n      \"pmids\": [\"35896696\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous dopamine engages this axis at physiological concentrations unknown\", \"Selectivity of the effect for astrocytes versus microglia or neurons not fully dissected\", \"Long-term in vivo neuroprotective efficacy not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for DRD3-selective activation of AMPK, the identity of palmitoyl transferases that modify DRD3, and how DRD3 heteromerization influences circuit-level functions remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of DRD3 in complex with GIPC1 or downstream effectors\", \"Epigenetic mechanisms by which early life stress downregulates Drd3 in lateral septum not identified\", \"Role of DRD3 heteromers (e.g., DRD1-DRD3) in any of the described circuits not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 4, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 6]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GIPC1\", \"NPAS2\"],\n    \"other_free_text\": []\n  }\n}\n```"}